Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

Video

» Topical Discussion

Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR

April 2, 2025

Video

» Topical Discussion

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

December 5, 2024

Video

» Topical Discussion

Next Generation TAVR Planning with DASI Simulations: Artificial Intelligence and Prediction-Based Algorithms

November 18, 2024

Video

» Topical Discussion

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

November 18, 2024

Video

» Topical Discussion

Cerebral Embolic Protection – A Next Generation Approach for Contemporary TAVR Practice

November 13, 2024

Video

» Topical Discussion

ShortCut™️: The Only FDA-Cleared Leaflet Modification Solution for Streamlining Complex TAVR Procedures

October 24, 2024

Video

» Topical Discussion

Discussing the SMART Trial: TAVR Patients With Small Aortic Annuli

July 17, 2024

Video

» Topical Discussion

Lifetime Management Considerations in Low Risk Patients

February 7, 2024

Video

» Topical Discussion

Understanding Early and Late Mortality in Low Risk Randomized Trials

February 7, 2024

Video

» Topical Discussion

High-Level Results of the Evolut™ Low Risk Randomized Clinical Trial

February 7, 2024

Video

» Topical Discussion

The Clinical Impact of Bioprosthetic Valve Performance After Surgery and TAVR

February 6, 2024

Video

» Topical Discussion

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team

February 6, 2024

Video

» Topical Discussion

Long-term Outcomes After TAVR

January 11, 2024

Video

» Topical Discussion

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

November 13, 2023

Video

» Topical Discussion

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial

November 8, 2023

Video

» Topical Discussion

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

September 30, 2022

Video

» Topical Discussion

Efficiency in Structural Heart TAVR TEER

August 31, 2021

Video

» Topical Discussion

High-risk Severe Aortic Regurgitation and TAVR

July 29, 2021

Video

» Topical Discussion

Innovations in Temporary Pacing: The Tempo Lead

May 3, 2021

Video

» Topical Discussion

CTO Decision Making: Sponsored by Medtronic

March 12, 2021

Advertisement

Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

Next Generation TAVR Planning with DASI Simulations: Artificial Intelligence and Prediction-Based Algorithms

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

Cerebral Embolic Protection – A Next Generation Approach for Contemporary TAVR Practice

ShortCut™️: The Only FDA-Cleared Leaflet Modification Solution for Streamlining Complex TAVR Procedures

Discussing the SMART Trial: TAVR Patients With Small Aortic Annuli

Lifetime Management Considerations in Low Risk Patients

Understanding Early and Late Mortality in Low Risk Randomized Trials

High-Level Results of the Evolut™ Low Risk Randomized Clinical Trial

The Clinical Impact of Bioprosthetic Valve Performance After Surgery and TAVR

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team

Long-term Outcomes After TAVR

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

Efficiency in Structural Heart TAVR TEER

High-risk Severe Aortic Regurgitation and TAVR

Innovations in Temporary Pacing: The Tempo Lead

CTO Decision Making: Sponsored by Medtronic

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content